Skip to content
News
About us
Contact
English
Search
Close
For Healthcare Professionals
For Women
Resources
Stay Informed
News
About us
Contact
English
Stay Informed
Menu
For Healthcare Professionals
For Women
Resources
Home
>
ASPIVIX Awarded Venture Kick Stage 1
ASPIVIX Awarded Venture Kick Stage 1
December 12, 2017
Share this story:
Share on Facebook
Share on Linkedin
Share on Twitter
More from our blog
ASPIVIX Announces That Contraception, an International Reproductive Health Journal, Has Published First-In-Women Results Using Novel Cervical Stabilizer In IUD Procedures
Read More
Aspivix receives U.S. FDA 510(k) Clearance for Carevix™, Their Novel Cervical Stabilizer
Read More
Aspivix mentioned in Femtech World about Serie A
Read More
ASPIVIX – Manufacturer of non-traumatic medical devices for gynecology – closes $5M Series A+ Funding Round and receives a large EUREKA-EUROSTARS grant co-funded by Innosuisse, the Swiss Innovation Agency.
Read More
10 Simple Steps Gynecologists Can Take to Enhance Patient Experience
Read More
5 Common Myths About Contraceptives
Read More
A modern approach to women’s healthcare
Read More
Clinical data show significantly lower IUD procedural pain and bleeding rates with Aspivix’s novel suction-based cervical device
Read More
Aspivix mentioned in Swissquote article about FemTech
Read More
Reshaping gynecology with women’s experience in mind
Read More